Additional file 11 of Focal adhesion kinase inhibitor TAE226 combined with Sorafenib slows down hepatocellular carcinoma by multiple epigenetic effects

Authors :: Romito, Ilaria
Porru, Manuela
Braghini, Maria Rita
Pompili, Luca
Panera, Nadia
Crudele, Annalisa
Gnani, Daniela
De Stefanis, Cristiano
Scarsella, Marco
Pomella, Silvia
Levi Mortera, Stefano
de Billy, Emmanuel
Conti, Adrian Libenzio
Marzano, Valeria
Putignani, Lorenza
Vinciguerra, Manlio
Balsano, Clara
Pastore, Anna
Rota, Rossella
Tartaglia, Marco
Leonetti, Carlo
Alisi, Anna
Publication Year :: 2021
Publisher :: figshare, 2021.
Abstract: Additional file 11: Figure S6. pTyr397FAK nuclear interactors before and after treatment with TAE226 > SOR. Representative images of immunofluorescence for pTyr397FAK, ��-Catenin, HDAC1 and HDAC2 in HepG2 and Huh7 cells NT and after TAE226 > SOR treatment. 60X Magnification.

Full Text Access

Tools